Table 4 Subgroup analysis of persons with viral load > 200 copies/ml after the initiation on ART
Parameter | Persistent viraemia group | Persistent viraemia group | p value |
|---|---|---|---|
n = 15 | n = 15 | ||
(Naïve) | (ART) | ||
CD4 count (cells/μl) | 277 (214 to 355) | 388 (209 to 529) | 0.009 |
CD8 count (cells/μl) | 980 (774 to 1536) | 671 (465 to 1018) | 0.005 |
HIV viral load (copies/ml) | 77,005 (7478 to 350,082) | 2389 (20 to 89,339) | 0.7 |
HIV viral load (log copies/ml) | 4.9 (3.9 to 5.5) | 3.4 (1.3* to 5.0) | 0.2 |
Presence of pericardial effusion | 10 (67%) | 11 (73%) | 0.7 |
Global T2 SIR | 1.5 ± 0.2 | 1.5 ± 0.2 | 0.5 |
Global native T1 mapping (ms) | 1040 ± 27 | 1033 ± 39 | 0.3 |
Global native T2 mapping (ms) | 48 ± 3 | 49 ± 3 | 0.4 |
Global ECV (%) | 27 ± 4 | 26 ± 3 | 0.1 |
EGE | 3.4 ± 1.1 | 3.3 ± 0.9 | 0.6 |
LGE present | 7 (47%) | 9 (60%) | 0.7 |